Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-034573
Filing Date
2022-02-10
Accepted
2022-02-10 16:46:08
Documents
2
Group Members
ANTONIO J. GRACIASJUAN A. SABATERVALOR EQUITY ASSOCIATES IV L.P.VALOR EQUITY CAPITAL IV LLCVALOR EQUITY PARTNERS IV L.P.VALOR EQUITY PARTNERS IV-A L.P.VALOR EQUITY PARTNERS IV-B L.P.VALOR MANAGEMENT L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d290131dsc13ga.htm SC 13G/A 133764
2 EX-99.1 d290131dex991.htm EX-99.1 20258
  Complete submission text file 0001193125-22-034573.txt   155926
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Subject) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91635 | Film No.: 22614789
SIC: 2834 Pharmaceutical Preparations

Mailing Address 875 N. MICHIGAN AVENUE SUITE 3214 CHICAGO IL 60611
Business Address 875 N. MICHIGAN AVENUE SUITE 3214 CHICAGO IL 60611 (312) 568-4766
Valor IV Pharma Holdings, LLC (Filed by) CIK: 0001821186 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A